Everything on Gender & Biology →
Primary documents
- “Detransitioner” sues doctors after being given irreversible gender treatments as child (2023)
News Report · 2023
The National Desk / Idaho News
The article quotes Kaiser’s public response that its care follows medical standards, includes multidisciplinary evaluation and support, and leaves decisions with patients and parents. This is…
- 15 CSR 60-17.010 Experimental Interventions to Treat Gender Dysphoria—Emergency Rule (2023)
Government Record · 2023
Missouri Attorney General
The 2023 emergency rule imposed conditions on specified interventions and originally stated an April 27 effective date and February 2024 expiration. Its actual early termination is…
- A Follow-Up Study of Boys With Gender Identity Disorder (2021)
Peer-Reviewed Study · 2021
Singh D, Bradley SJ, Zucker KJ
Largest follow-up of clinic-referred boys (n=139, CAMH Toronto, assessed 1975-2009): 87.8% desisted at follow-up. The paper itself addresses critiques of desistance methodology (threshold vs subthreshold diagnosis;…
- AAP reaffirms gender-affirming care policy, authorizes systematic review of evidence (2023)
Peer-Reviewed Study · 2023
AAP News (American Academy of Pediatrics)
In August 2023 the AAP simultaneously reaffirmed its 2018 gender-affirming-care policy and authorized a systematic evidence review – i.e., it restated its position before, not after,…
- AbbVie 2021 Fourth-Quarter and Full-Year Earnings Exhibit (2022)
Corporate Filing · 2022
AbbVie Inc.
AbbVie’s earnings exhibit reports 2021 Lupron revenue of $604 million in the United States and $179 million internationally, totaling $783 million. This is product-wide revenue and…
- An Evidence-Based Critique of ‘The Cass Review’ on Gender-affirming Care for Adolescent Gender Dysphoria (2024)
Document · 2024
McNamara M, Baker K, Connelly K, Janssen A, Olson-Kennedy J, Pang KC, et al. (Yale Integrity Project)
39-page critique by Yale-led clinicians/scholars alleging the Cass Review misapplies evidence-based medicine, misrepresents its own data, and that the commissioned York systematic reviews have serious methodological…
- Arcus Foundation Form 990, Tax Year 2023
Corporate Filing · 2023
Arcus Foundation
Arcus’s 2023 return records $100,000 to Campaign for Southern Equality for the Southern Trans Youth Emergency Project. Other selected entries are $765,087 to Borealis Philanthropy for…
- Ban on puberty blockers to be made indefinite on experts’ advice (2024)
Government Record · 2024
UK Department of Health and Social Care
Announces the indefinite UK-wide ban on sale/supply of puberty blockers for under-18s (private and EEA/Swiss prescribers), in force 1 January 2025 with first review in 2027,…
- Bell and another v The Tavistock and Portman NHS Foundation Trust [2021] EWCA Civ 1363
Court Filing · 2021
Court of Appeal (Civil Division) (Lord Burnett LCJ, Vos MR, King LJ)
Court of Appeal reversed the Divisional Court: Gillick competence assessments are for clinicians, not courts; judicial-review claim dismissed. It was 'for doctors and not judges to…
- Brief of the State of Alabama and 22 Other States as Amici Curiae in Support of Respondents, U.S. v. Skrmetti, No. 23-477 (2024)
Court Filing · 2024
State of Alabama et al. (Steve Marshall, AG)
Court filing compiling evidence from Boe v. Marshall (2:22-cv-184, M.D. Ala.) discovery: WPATH commissioned systematic reviews from a Johns Hopkins team, blocked publication of most, removed…
- Brockman v. Kaiser Foundation Hospitals, C101451 (2025)
Court Filing · 2025
California Court of Appeal, Third Appellate District
The appellate court affirmed denial of Kaiser’s petition to compel arbitration because Kaiser did not prove a valid, binding arbitration agreement. The opinion summarizes Cole’s allegations…
- Children’s Hospital Los Angeles Ends Transgender Care (2025)
News Report · 2025
KQED / KCRW
KQED reports that CHLA ended the program on July 22, 2025, affecting nearly 3,000 patients, and quotes CHLA’s statement about federal funding pressure.
- Children’s National Hospital Statement on Executive Order (2025)
Document · 2025
Children’s National Hospital
Children’s National said it was pausing puberty-blocker and hormone prescriptions and already did not perform gender-affirming surgery for minors. It promised continued mental-health counseling, social support,…
- Chloe Cole v. Kaiser Foundation Hospitals—Case Resource (2026)
Document · 2026
Center for American Liberty
Cole’s counsel reports that the complaint was filed February 22, 2023, pretrial proceedings were underway as of April 2026, and trial was anticipated for April 5,…
- Clinical Policy: Puberty suppressing hormones (PSH) for children and young people who have gender incongruence or gender dysphoria (2024)
Government Record · 2024
NHS England
NHS England's March 2024 commissioning policy ending routine NHS prescription of puberty blockers to under-18s for gender dysphoria, following the Cass Review. Blockers thereafter only within…
- Correction: Rapid-onset gender dysphoria in adolescents and young adults: A study of parental reports (2019)
Peer-Reviewed Study · 2019
Littman L / PLOS ONE editors
March 2019 correction/republication following post-publication review: Title, Abstract, Introduction, Discussion and Conclusion revised; Results unchanged; clarifies ROGD is not a formal diagnosis and the study does…
- Critically appraising the Cass report: methodological flaws and unsupported claims (2025)
Peer-Reviewed Study · 2025
(peer-reviewed critical appraisal; PMC12065279)
Peer-reviewed critical appraisal arguing the Cass-commissioned systematic reviews had protocol deviations, no pre-defined analysis plans, and selective emphasis – the methodological challenge side, complementing the Yale…
- Critiques of the Cass Review: Fact-Checking the Peer-Reviewed Literature (2025)
Peer-Reviewed Study · 2025
McDeavitt K, Cantor J, et al.
Peer-reviewed response to the Yale Integrity Project and other Cass critiques, arguing the published critiques misstate the Review's methods and findings. James Cantor's related 2025 analysis…
- Current CSR Record for 15 CSR 60-17.010 (2023)
Government Record · 2023
Missouri Secretary of State
The official current CSR record states that the emergency rule was terminated on May 16, 2023. It is not current law.
- Department of Justice Subpoenas Doctors and Clinics Involved in Performing Transgender Medical Procedures on Children (2025)
Government Record · 2025
U.S. Department of Justice
DOJ announced more than 20 subpoenas and described investigations including healthcare fraud and false statements. The release announces investigations, not adjudicated violations.
- Docket, L.W. v. Skrmetti, No. 3:23-cv-00376 (2023)
Court Filing · 2023
U.S. District Court for the Middle District of Tennessee
The federal docket records three civil investigative demands to VUMC as exhibits filed on June 1, 2023. It establishes that the demands entered the court record,…
- DOJ Secures Agreements with NYU and UPMC to End Pediatric “Gender-Affirming Care” (2026)
Government Record · 2026
U.S. Department of Justice
DOJ announced NYU and UPMC agreements to end pediatric interventions and pay $8.5 million and $950,000 respectively, and reported similar agreements with four other systems. The…
- Endo Pharmaceuticals Holdings Inc. 2009 Form 10-K (2010)
Corporate Filing · 2010
Endo Pharmaceuticals Holdings Inc.
Endo’s 2009 Form 10-K reports $27.8 million in Supprelin LA net sales. It describes marketing primarily to pediatric endocrinologists for central precocious puberty, not gender dysphoria.
- Endo Reports Fourth-Quarter and Full-Year 2024 Financial Results (2025)
Corporate Filing · 2025
Endo, Inc.
Endo reports full-year 2024 Supprelin LA revenue of $85.520 million, compared with $96.849 million in 2023. These are product-wide figures and do not identify revenue or…